Document is current
Any future updates will be listed below
-
Authors
Bassi, Francesco https://orcid.org/0009-0004-4180-2533
Miladinović, Aleksandar https://orcid.org/0000-0002-6156-1464
Accardo, Agostino https://orcid.org/0000-0001-5749-6308
-
Funding
Funding for this research was provided by:
Università degli Studi di Trieste
- License Information
-
More Information
Article History
Received: 21 July 2025
Accepted: 24 November 2025
First Online: 5 December 2025
Declarations
:
: Agostino Accardo and Aleksandar Miladinović report a relationship with Neuranix Srl, Napoli, Italy that includes: consulting or advisory. Francesco Bassi declares no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The data collection phase was funded by Neuranix.
: The Clinical Trial was approved by the Ethics Committees of all six participating institutions, beginning with the lead institution, IRCCS ”A. Gemelli” Hospital in Rome (Prot. 5389, January 19, 2023), and, as required by Italian regulations, by the Italian Ministry of Health (MEDWAVE-2, Clinical Trial number: IT-23-03-042692, May 9, 2023). Informed consent was obtained from all adult participants, and for minors, consent was provided by a parent or legal guardian.
: The Clinical Trial was approved by the Italian Ministry of Health with the following details: Study code "MEDWAVE-2", Study number IT-23-03-042692, date of approval 9 May 2023, Study title "Utilizzo dello strumento Med-Wave per la diagnosi di patologie dell’orecchio in pazienti pediatrici e adulti".
